Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of “Moderate Buy” from Analysts

Smith & Nephew plc (NYSE:SNN) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company.

Several equities analysts have recently issued reports on SNN shares. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft began coverage on shares of Smith & Nephew in a research note on Wednesday, July 24th. They set a “buy” rating on the stock. Finally, UBS Group raised shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research note on Wednesday, June 5th.

Institutional Trading of Smith & Nephew

A number of hedge funds and other institutional investors have recently made changes to their positions in SNN. CWM LLC boosted its stake in shares of Smith & Nephew by 68.6% during the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 388 shares in the last quarter. Spire Wealth Management raised its holdings in Smith & Nephew by 224.3% during the fourth quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 702 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Smith & Nephew by 75.0% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 526 shares during the last quarter. Parallel Advisors LLC lifted its position in Smith & Nephew by 150.9% during the 4th quarter. Parallel Advisors LLC now owns 1,533 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 922 shares during the last quarter. Finally, Mather Group LLC. grew its holdings in Smith & Nephew by 9,735.3% in the 2nd quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 1,655 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Trading Down 3.3 %

SNN stock opened at $29.44 on Thursday. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. Smith & Nephew has a fifty-two week low of $21.52 and a fifty-two week high of $31.13. The firm’s 50-day simple moving average is $26.62 and its 200 day simple moving average is $26.40.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.